Tissue | Expression Dynamics | Abbreviation |
Breast | ![The image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.](images/deg_images/Breast/FABP5_pca_on_diff_genes.png) | IDC: Invasive ductal carcinoma |
DCIS: Ductal carcinoma in situ |
Precancer(BRCA1-mut): Precancerous lesion from BRCA1 mutation carriers |
Cervix | ![The image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.](images/deg_images/Cervix/FABP5_pca_on_diff_genes.png) | CC: Cervix cancer |
HSIL_HPV: HPV-infected high-grade squamous intraepithelial lesions |
N_HPV: HPV-infected normal cervix |
Endometrium | ![The image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.](images/deg_images/Endometrium/FABP5_pca_on_diff_genes.png) | AEH: Atypical endometrial hyperplasia |
EEC: Endometrioid Cancer |
Esophagus | ![The image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.](images/deg_images/Esophagus/FABP5_pca_on_diff_genes.png) | ESCC: Esophageal squamous cell carcinoma |
HGIN: High-grade intraepithelial neoplasias |
LGIN: Low-grade intraepithelial neoplasias |
GC | ![The image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.](images/deg_images/GC/FABP5_pca_on_diff_genes.png) | CAG: Chronic atrophic gastritis |
CAG with IM: Chronic atrophic gastritis with intestinal metaplasia |
CSG: Chronic superficial gastritis |
GC: Gastric cancer |
SIM: Severe intestinal metaplasia |
WIM: Wild intestinal metaplasia |
Liver | ![The image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.](images/deg_images/Liver/FABP5_pca_on_diff_genes.png) | HCC: Hepatocellular carcinoma |
NAFLD: Non-alcoholic fatty liver disease |
Oral Cavity | ![The image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.](images/deg_images/OralCavity/FABP5_pca_on_diff_genes.png) | EOLP: Erosive Oral lichen planus |
LP: leukoplakia |
NEOLP: Non-erosive oral lichen planus |
OSCC: Oral squamous cell carcinoma |
Prostate | ![The image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.](images/deg_images/Prostate/FABP5_pca_on_diff_genes.png) | BPH: Benign Prostatic Hyperplasia |
Skin | ![The image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.](images/deg_images/Skin/FABP5_pca_on_diff_genes.png) | AK: Actinic keratosis |
cSCC: Cutaneous squamous cell carcinoma |
SCCIS:squamous cell carcinoma in situ |
Thyroid | ![The image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.](images/deg_images/Thyroid/FABP5_pca_on_diff_genes.png) | ATC: Anaplastic thyroid cancer |
HT: Hashimoto's thyroiditis |
PTC: Papillary thyroid cancer |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:00066333 | Stomach | SIM | fatty acid biosynthetic process | 19/708 | 163/18723 | 1.34e-05 | 4.65e-04 | 19 |
GO:00421802 | Stomach | SIM | cellular ketone metabolic process | 22/708 | 211/18723 | 1.73e-05 | 5.57e-04 | 22 |
GO:00105651 | Stomach | SIM | regulation of cellular ketone metabolic process | 16/708 | 133/18723 | 4.30e-05 | 1.21e-03 | 16 |
GO:00723302 | Stomach | SIM | monocarboxylic acid biosynthetic process | 21/708 | 214/18723 | 6.55e-05 | 1.70e-03 | 21 |
GO:00015164 | Stomach | SIM | prostaglandin biosynthetic process | 7/708 | 31/18723 | 1.28e-04 | 2.94e-03 | 7 |
GO:00464574 | Stomach | SIM | prostanoid biosynthetic process | 7/708 | 31/18723 | 1.28e-04 | 2.94e-03 | 7 |
GO:00192161 | Stomach | SIM | regulation of lipid metabolic process | 27/708 | 331/18723 | 1.58e-04 | 3.50e-03 | 27 |
GO:00192171 | Stomach | SIM | regulation of fatty acid metabolic process | 12/708 | 93/18723 | 1.96e-04 | 4.08e-03 | 12 |
GO:00464563 | Stomach | SIM | icosanoid biosynthetic process | 9/708 | 56/18723 | 2.31e-04 | 4.63e-03 | 9 |
GO:00468901 | Stomach | SIM | regulation of lipid biosynthetic process | 17/708 | 171/18723 | 2.71e-04 | 5.21e-03 | 17 |
GO:00620123 | Stomach | SIM | regulation of small molecule metabolic process | 26/708 | 334/18723 | 4.29e-04 | 7.26e-03 | 26 |
GO:00066361 | Stomach | SIM | unsaturated fatty acid biosynthetic process | 8/708 | 51/18723 | 6.07e-04 | 9.20e-03 | 8 |
GO:00108764 | Stomach | SIM | lipid localization | 30/708 | 448/18723 | 1.87e-03 | 2.08e-02 | 30 |
GO:004259331 | Stomach | SIM | glucose homeostasis | 20/708 | 258/18723 | 1.99e-03 | 2.16e-02 | 20 |
GO:003350031 | Stomach | SIM | carbohydrate homeostasis | 20/708 | 259/18723 | 2.08e-03 | 2.23e-02 | 20 |
GO:00068693 | Stomach | SIM | lipid transport | 27/708 | 398/18723 | 2.58e-03 | 2.55e-02 | 27 |
GO:003052228 | Thyroid | PTC | intracellular receptor signaling pathway | 126/5968 | 265/18723 | 6.31e-08 | 1.31e-06 | 126 |
GO:001931810 | Thyroid | PTC | hexose metabolic process | 108/5968 | 237/18723 | 6.42e-06 | 7.65e-05 | 108 |
GO:000599614 | Thyroid | PTC | monosaccharide metabolic process | 115/5968 | 257/18723 | 9.36e-06 | 1.05e-04 | 115 |
GO:000600615 | Thyroid | PTC | glucose metabolic process | 90/5968 | 196/18723 | 2.54e-05 | 2.50e-04 | 90 |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
FABP5 | deletion | Frame_Shift_Del | novel | c.47delG | p.Ser16ThrfsTer8 | p.S16Tfs*8 | Q01469 | protein_coding | | | TCGA-EW-A2FV-01 | Breast | breast invasive carcinoma | Female | <65 | III/IV | Chemotherapy | docetaxel | SD |
FABP5 | SNV | Missense_Mutation | novel | c.4N>A | p.Ala2Thr | p.A2T | Q01469 | protein_coding | deleterious_low_confidence(0.05) | benign(0.309) | TCGA-AA-3949-01 | Colorectum | colon adenocarcinoma | Female | >=65 | III/IV | Unknown | Unknown | SD |
FABP5 | SNV | Missense_Mutation | novel | c.165N>C | p.Lys55Asn | p.K55N | Q01469 | protein_coding | deleterious(0.02) | benign(0.345) | TCGA-CA-6717-01 | Colorectum | colon adenocarcinoma | Male | <65 | I/II | Chemotherapy | oxaliplatin | CR |
FABP5 | SNV | Missense_Mutation | novel | c.312N>C | p.Glu104Asp | p.E104D | Q01469 | protein_coding | deleterious(0.02) | possibly_damaging(0.84) | TCGA-F5-6814-01 | Colorectum | rectum adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | SD |
FABP5 | SNV | Missense_Mutation | | c.346N>A | p.Leu116Ile | p.L116I | Q01469 | protein_coding | deleterious(0.01) | possibly_damaging(0.712) | TCGA-AP-A0LT-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
FABP5 | SNV | Missense_Mutation | rs763394711 | c.263A>G | p.Asn88Ser | p.N88S | Q01469 | protein_coding | tolerated(0.17) | benign(0.001) | TCGA-B5-A0JY-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Chemotherapy | doxorubicin | SD |
FABP5 | SNV | Missense_Mutation | novel | c.4G>A | p.Ala2Thr | p.A2T | Q01469 | protein_coding | deleterious_low_confidence(0.05) | benign(0.309) | TCGA-B5-A3FC-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
FABP5 | SNV | Missense_Mutation | rs201701039 | c.386G>A | p.Arg129Gln | p.R129Q | Q01469 | protein_coding | deleterious(0.03) | benign(0.345) | TCGA-B5-A3FC-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
FABP5 | SNV | Missense_Mutation | novel | c.152N>T | p.Asn51Ile | p.N51I | Q01469 | protein_coding | tolerated(0.41) | benign(0.346) | TCGA-39-5034-01 | Lung | lung squamous cell carcinoma | Female | >=65 | I/II | Unknown | Unknown | PD |
FABP5 | SNV | Missense_Mutation | rs757111208 | c.314N>T | p.Ser105Ile | p.S105I | Q01469 | protein_coding | deleterious(0.04) | probably_damaging(0.987) | TCGA-60-2723-01 | Lung | lung squamous cell carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |